Showing results (1771-1780 of 1,795) with videos related to
Sort By:
Pageof 180
Journal of Cancer Research and Therapeutics|August 29, 2024
Chinese guidelines for integrated diagnosis and treatment of intestinal microecology technologies in tumor application (2024 Edition)Qiang Wang, Mingxin He, Jing Liang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority TrialXiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.Nature Communications|March 31, 2026
Concurrent chemoradiotherapy plus nimotuzumab versus chemoradiotherapy alone for locoregionally advanced nasopharyngeal carcinoma with a suboptimal response to induction chemotherapy: a randomized phase 2 trialLi-Ting Liu, Xue-Song Sun, Ting-Ting Quan, et al.Journal of Medical Virology|July 10, 2022
Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective studyXiaolong Qi, Jitao Wang, Qiran Zhang, et al.Journal of Gastroenterology and Hepatology|August 26, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3bFanpu Ji, Jie Li, Li Liu, et al.Journal of Cancer Research and Therapeutics|January 17, 2023
Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022)Jun Wang, Jing Liang, Mingxin He, et al.Nature Nanotechnology|November 16, 2021
Dual-coupling-guided epitaxial growth of wafer-scale single-crystal WS2 monolayer on vicinal a-plane sapphireJinhuan Wang, Xiaozhi Xu, Ting Cheng, et al.The Lancet. Oncology|November 10, 2024
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trialSai-Lan Liu, Xiao-Yun Li, Jin-Hao Yang, et al.The Lancet. Oncology|June 8, 2023
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trialLi-Ting Liu, Huai Liu, Ying Huang, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2025
[18F] Fluorodeoxyglucose positron emission tomography/computed tomography scan and liquid biopsy at 12 weeks posttreatment for surveillance of locoregionally advanced nasopharyngeal carcinomaLi-Ting Liu, Zhen-Chong Yang, Jia-Rui He, et al.Pageof 180